MMP8 and Alzheimer disease: In relation to the possible diagnostic potential of the 35 proteases studied in this research, after logistic model evaluations, it was revealed that a single use of MMP8 allowed for the correct identification of both conditions (AD and healthy subjects), indicating that the GCF could serve as a novel and non-invasive source for potential diagnostic biomarkers of moderate/severe AD.